Plain-English translation of NCT07178210 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new robotic surgical system called the Symani System to treat Alzheimer's disease by improving the brain's natural ability to clear out toxic proteins like amyloid-beta and tau. The surgery targets small lymph vessels in the neck and head that may not be working properly in Alzheimer's patients. Researchers believe that by using this robotic technology to perform very precise microsurgery, they can help the brain better remove these harmful proteins.
Current Alzheimer's treatments have limited success because the disease involves buildup of toxic proteins in the brain. If doctors can improve how efficiently the brain clears these proteins through its natural drainage system, it may slow or reduce Alzheimer's symptoms.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo robotic-assisted microsurgery performed by trained surgeons using the Symani System to improve lymphatic drainage in your neck and head region. You will also need to return for multiple follow-up visits so doctors can monitor your safety, check how well the surgery worked, and see if it helps your Alzheimer's symptoms. The study involves imaging scans, memory and thinking tests, and careful monitoring of your recovery over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States